Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part B

Author:

Röth Alexander,Berentsen Sigbjørn,Barcellini Wilma,D’Sa Shirley,Jilma Bernd,Michel Marc,Weitz Ilene C.,Yamaguchi Masaki,Nishimura Jun-ichi,Vos Josephine M.I.,Cid Joan,Storek Michael,Wong Nancy,Yoo Ronnie,Jayawardene Deepthi,Srivastava Shruti,Wardęcki Marek,Shafer Frank,Lee Michelle,Broome Catherine M.

Publisher

Elsevier BV

Reference24 articles.

1. Cold agglutinin disease: a distinct clonal B-cell lymphoproliferative disorder of the bone marrow;Climent;Hemato,2022

2. Cold agglutinin disease: where do we stand, and where are we going?;Berentsen;Clin Adv Hematol Oncol,2020

3. Cold agglutinin disease;Swiecicki;Blood,2013

4. New insights in the pathogenesis and therapy of cold agglutinin-mediated autoimmune hemolytic anemia;Berentsen;Front Immunol,2020

5. Primary chronic cold agglutinin disease: a population based clinical study of 86 patients;Berentsen;Haematologica,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3